TScan Therapeutics, Inc.TCRXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-132.95M
↓ 95% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-68.10M
Historical baseline
PeriodValueYoY Change
TTM$-132.95M-11.0%
2024$-119.74M-49.5%
2023$-80.10M-33.7%
2022$-59.91M-32.3%
2021$-45.30M-81.2%
2020$-25.00M-82.6%
2019$-13.69M-